The purpose of this update was to examine interval evidence of the acceptance and impact of the 2007 recommendations on viridans group streptococcal infective endocarditis and to make any necessary revisions based on this evidence.
While cardiovascular disease may be common and commonly known to patients, they may not know some of the surprising factors in their diet and medical history that may actually be putting them at risk. What are some of the cardiovascular disease risk factors patients should know about?
This study evaluated the effects of a 12-month intensive prevention program based on regular contacts between nonphysician “prevention assistants” and patients who had had an MI.
Investigators assessed outcomes following discontinuation of statins while maintaining the use of other drugs in older patients receiving polypharmacy.
HOPE-3 was designed to assess if reducing BP and/or LDL-C would reduce cardiovascular events in study participants at intermediate risk with no prior cardiovascular events.
Commercial wearable devices containing sensors can predict clinical laboratory measurements, including a more precise depiction of resting heart rate, than measurements taken in the clinic.
For older patients with decompensated heart failure, a tailored rehabilitation intervention results in greater improvement in physical function than usual care.
In a guideline issued by the American Heart Association/American Stroke Association and published online May 24 in Stroke, recommendations are presented for prevention of a second stroke.
